Apo A5 −1131T/C, FgB −455G/A, −148C/T, and CETP TaqIB gene polymorphisms and coronary artery disease in the Chinese population: a meta-analysis of 15,055 subjects

[1]  Z. Rahimi,et al.  Association between cholesteryl ester transfer protein TaqIB variants and risk of coronary artery disease and diabetes mellitus in the population of western Iran. , 2011, Genetic testing and molecular biomarkers.

[2]  C. Stefanadis,et al.  Fibrinogen and cardiovascular disease: genetics and biomarkers. , 2011, Blood reviews.

[3]  D. Fang,et al.  Apolipoprotein A5 polymorphisms and risk of coronary artery disease: a meta-analysis. , 2011, Bioscience trends.

[4]  Zhai Guanghua,et al.  APOA5 −1131T/C polymorphism is associated with coronary artery disease in a Chinese population: a meta-analysis , 2011 .

[5]  Xiang Ma,et al.  [Association of apolipoprotein A5 gene polymorphism with coronary heart disease in Uygur population of Xinjiang]. , 2011, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[6]  Y. Nişancı,et al.  Cholesteryl ester transfer protein Taq1B polymorphism in an angiographically assessed Turkish population: no effects on coronary artery disease risk. , 2010, Genetic testing and molecular biomarkers.

[7]  D. Corella,et al.  Common cholesteryl ester transfer protein gene variation related to high-density lipoprotein cholesterol is not associated with decreased coronary heart disease risk after a 10-year follow-up in a Mediterranean cohort: Modulation by alcohol consumption. , 2010, Atherosclerosis.

[8]  G. Nijpels,et al.  Fasting cholesteryl ester transfer protein concentration is independently associated with the postprandial decrease in high-density lipoprotein cholesterol concentration after fat-rich meals: the Hoorn prandial study. , 2010, Metabolism: clinical and experimental.

[9]  A. Manolis,et al.  Lack of Association Between the Cholesteryl Ester Transfer Protein Gene—TaqIB Polymorphism and Coronary Restenosis Following Percutaneous Transluminal Coronary Angioplasty and Stenting: A Pilot Study , 2010, Angiology.

[10]  J. Ordovás,et al.  Apolipoprotein A5 and Lipoprotein Lipase Interact to Modulate Anthropometric Measures in Hispanics of Caribbean Origin , 2010, Obesity.

[11]  A. Gotto,et al.  Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis , 2009, BMC Medical Genetics.

[12]  Ying Wang,et al.  Association between -455G/A and fibrinogen in a Chinese population , 2009, Acta cardiologica.

[13]  M. Firoozrai,et al.  Taq1B polymorphism of cholesteryl ester transfer protein (CETP) gene in primary combined hyperlipidaemia. , 2009, The Indian journal of medical research.

[14]  Ying Wang,et al.  Association of Fibrinogen and Fibrinogen Gene β148 and β854 Polymorphisms with Coronary Heart Disease , 2008, Cardiology.

[15]  Yangeng Yu,et al.  [Study on polymorphism in the apolipoprotein A5 gene in patients with premature coronary heart disease]. , 2007, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.

[16]  M. Hsieh,et al.  Cholesteryl ester transfer protein B1B1 genotype as a predictor of coronary artery disease in Taiwanese with type 2 diabetes mellitus. , 2007, Metabolism: clinical and experimental.

[17]  L. Hsu,et al.  Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. , 2006, Atherosclerosis.

[18]  Shah Ebrahim,et al.  Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?: Evidence from a Meta-Analysis of Genetic Association Studies , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[19]  Le-ming Fan,et al.  Association between apolipoprotein A5 - 1131T > C polymorphism and susceptibility of coronary artery disease in Chinese. , 2005, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[20]  D. Nebert,et al.  Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. , 2005, Metabolism: clinical and experimental.

[21]  Zhi-nong Yin,et al.  [Polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene in patients with coronary artery disease]. , 2005, Zhonghua xin xue guan bing za zhi.

[22]  P J Talmud,et al.  Cholesteryl Ester Transfer Protein TaqIB Variant, High-Density Lipoprotein Cholesterol Levels, Cardiovascular Risk, and Efficacy of Pravastatin Treatment: Individual Patient Meta-Analysis of 13 677 Subjects , 2005, Circulation.

[23]  朱文玲,et al.  Relationship between coronary heart disease and Taq I B & Msp I polymorphisms of Cholesteryl ester transfer protein gene in Hah nationality , 2004 .

[24]  Z. Prohászka,et al.  Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. , 2004, Atherosclerosis.

[25]  V. Lánská,et al.  The influence of APOAV polymorphisms (T‐1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction , 2004, Clinical genetics.

[26]  A. Evans,et al.  C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease: The PRIME Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[27]  Jonathan C. Cohen,et al.  Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. , 2002, Human molecular genetics.

[28]  S. Tomura,et al.  Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren , 2002, Human Genetics.

[29]  Q. Dang,et al.  [The relationship of beta-fibrinogen gene polymorphisms and ischaemic cardiocerebral vascular disease]. , 2002, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[30]  Jonathan C. Cohen,et al.  An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.

[31]  Wang-Wei Cai,et al.  [Effect of beta-Fibrinogen-455 Gene Polymorphism on Plasma Fibrinogen Levels in Patients with Ischemic Stroke] , 2001, Zhongguo shi yan xue ye xue za zhi.

[32]  P. Wilson,et al.  Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[33]  J. Ordovás,et al.  Genetic Polymorphisms and Activity of Cholesterol Ester Transfer Protein (CETP): Should We Be Measuring Them? , 2000, Clinical chemistry and laboratory medicine.

[34]  G. Fuller,et al.  Detection of a complex that associates with the Bbeta fibrinogen G-455-A polymorphism. , 1998, Blood.

[35]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[36]  J. Danesh,et al.  Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.

[37]  Richard H. Myers,et al.  Familial Lipoprotein Disorders in Patients With Premature Coronary Artery Disease , 1992, Circulation.

[38]  J. Sowers,et al.  Relation between lipids and atherosclerosis: epidemiologic evidence and clinical implications. , 1990, The American journal of cardiology.

[39]  S. Humphries,et al.  ROLE OF GENETIC VARIATION AT THE FIBRINOGEN LOCUS IN DETERMINATION OF PLASMA FIBRINOGEN CONCENTRATIONS , 1987, The Lancet.

[40]  T W Meade,et al.  Hypercoagulability and ischaemic heart disease. , 1987, Blood reviews.

[41]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[42]  C. Junien,et al.  The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2. , 1984, American journal of human genetics.

[43]  W. G. Cochran.  The effectiveness of adjustment by subclassification in removing bias in observational studies. , 1968, Biometrics.

[44]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[45]  Meifen Li,et al.  APOA5 -1131T/C polymorphism is associated with coronary artery disease in a Chinese population: a meta-analysis. , 2011, Clinical chemistry and laboratory medicine.

[46]  W. Zhen.  Determination of cholesterol ester transport protein gene polymorphism in patients with coronal heart disease from Hainan Li nationality , 2010 .

[47]  Wang Haokun,et al.  Relationship between gene polymorphism of fibrinogen β-148C/T and coronary heart disease , 2009 .

[48]  Sheng-huang Wang,et al.  [Geographical characteristics of single nucleotide polymorphism of candidate genes associated with coronary artery disease in Chinese Han population]. , 2008, Zhonghua xin xue guan bing za zhi.

[49]  He Tao.  Correlation of apolipoprocein A5 SNP3 gene single nucleotide polymorphism with coronary artery disease in Chinese , 2008 .

[50]  W. Liansheng.  Association of APOA5 gene-1131T/C single nucleotide polymorphism with coronary heart disease among Chinese Han population , 2007 .

[51]  Li Wei.  Nucleotide Polymorphisms and Haplotypes in α-and β-Fibrinogen Genes and Their Relationship to Coronary Heart Disease , 2007 .

[52]  C. Sen.  Research of association between βFibrinogen gene-455nt G/A polymorphism and acute myocardial infarction , 2007 .

[53]  P. Min.  Association of two polymorphisms in the fibrinogen Bβ gene 5′ promoter region with plasma levels and coronary artery disease susceptibility in Chinese population , 2007 .

[54]  Sheng-kai Yan,et al.  Apolipoprotein A5 gene polymorphism –1131T→C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese , 2005, Clinical chemistry and laboratory medicine.

[55]  M. Hui.  Association of Fibrinogen and Its Gene β148 and β854 Polymorphisms with Coronary Heart Disease , 2005 .

[56]  T. Isbir,et al.  Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients , 2005, Cell biochemistry and function.

[57]  Zhang Guo.  Relationship of Taq IB Polymorphism in the Cholesteryl Ester Transfer Protein Gene to Coronary Artery Disease , 2005 .

[58]  Wang Wei,et al.  Association of the TaqIB polymorphism and D442G mutation of cholesteryl ester transfer protein gene with coronary heart disease , 2004 .

[59]  Cui Rang-zhuang.  A Study on Bβ-Fibrinogen -148C/T Polymorphism and Platelet Membrane Glycoprotein VI T13254C Polymorphism of Coronary Heart Disease , 2004 .

[60]  S. Hui.  Association of Fibrinogen β-455G/A Gene Polymorphism with Hypertension and Coronary Heart Disease , 2004 .

[61]  Yan Sheng-kai.  Relationship between coronary heart disease and Taq I B & Msp I polymorphisms of Cholesteryl ester transfer protein gene in Han nationality , 2004 .

[62]  Z. Xiaoying.  Study of fibrinogen Bβ-148C/T gene polymorphism in patients with coronary heart disease and stroke , 2003 .

[63]  Lu Cheng-zhi.  Plasma Fibrinogen gene β-455G/A Polymorphism and plasma fibrinogen level in Patients with Acute Coronary Syndromes , 2003 .

[64]  Jin Wei.  Relationship between Single Nucleotide Polymorphisms in the 5'-Promoter Region of Beta Fibrinogen Gene and Coronary Artery Disease:A Case-Control Study in Chinese Population. , 2002 .

[65]  Gongjin Wu.  Study on the Promoter Region of Bβ-Fibrinogen Gene Polymorphism in Patients with Coronary Heart Disease , 2002 .

[66]  R. Krauss.  Dietary and genetic effects on LDL heterogeneity. , 2001, World review of nutrition and dietetics.

[67]  Li Feng.  β-Fibrinogen-455 gene polymorphism associated with plasma fibrinogen levels in Ischemic Heart Disease (IHD) , 2001 .

[68]  P. Reitsma,et al.  Apolipoprotein A-V A NOVEL APOLIPOPROTEIN ASSOCIATED WITH AN EARLY PHASE OF LIVER REGENERATION* , 2001 .

[69]  F. Green,et al.  Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A −455 (HaeIII), C/T −148 (HindIII/AluI), T/G+1689 (AvaII), and BclI (β‐fibrinogen) and TaqI (α‐fibrinogen), and their detection by PCR , 1994 .